{"filing":{"accession_number":"0001829126-26-005814","cik":"0002006815","ticker":"VACHW","company_name":"Voyager Acquisition Corp./Cayman Islands","form":"8-K","filing_date":"2026-05-29","report_date":null,"primary_document":"voyageracq_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2006815/000182912626005814/voyageracq_8k.htm"},"events":[{"id":8272,"run_id":7261,"accession_number":"0001829126-26-005814","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"This Item 1.01 discloses entry into material definitive agreements in connection with a deSPAC transaction (business combination). The filing describes a Securities Purchase Agreement for $27.5 million in senior secured notes and warrants, plus a Lincoln Park Capital Fund purchase agreement for up to $50 million in equity, all contingent on completion of the merger between Voyager Acquisition Corp. and Veraxa Biotech entities. These are material financing arrangements directly tied to the contemplated change of control transaction.","company_name":"Voyager Acquisition Corp./Cayman Islands","ticker":"VACHW","filing_date":"2026-05-29","form":"8-K","submitted_at":null,"items":[{"id":2911,"accession_number":"0001829126-26-005814","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"This Item 1.01 discloses entry into material definitive agreements in connection with a deSPAC transaction (business combination). The filing describes a Securities Purchase Agreement for $27.5 million in senior secured notes and warrants, plus a Lincoln Park Capital Fund purchase agreement for up to $50 million in equity, all contingent on completion of the merger between Voyager Acquisition Corp. and Veraxa Biotech entities. These are material financing arrangements directly tied to the contemplated change of control transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:41:23.271135+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2911,"accession_number":"0001829126-26-005814","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"This Item 1.01 discloses entry into material definitive agreements in connection with a deSPAC transaction (business combination). The filing describes a Securities Purchase Agreement for $27.5 million in senior secured notes and warrants, plus a Lincoln Park Capital Fund purchase agreement for up to $50 million in equity, all contingent on completion of the merger between Voyager Acquisition Corp. and Veraxa Biotech entities. These are material financing arrangements directly tied to the contemplated change of control transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:41:23.271135+00:00","company_name":"Voyager Acquisition Corp./Cayman Islands","ticker":"VACHW","filing_date":"2026-05-29"}]}